Axis Mutual Fund

Axis NIFTY Healthcare ETF-Growth

Equity: Sectoral-Pharma - Growth (Open ended)
Axis NIFTY Healthcare ETF-GrowthNAV: 165.33 as on 23 Jul, 2026
Risk levelCategoryBenchmark
Copyright © 2026 sharpely. All rights reserved.
Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
₹164.94-0.32%
24 Jul 2026

Tracking Difference

Annualised return gap between Axis NIFTY Healthcare ETF-Growth and its benchmark index over 1Y, 3Y, 5Y and 10Y periods, compared to the average of all funds tracking the same benchmark.
Name1 Y3 Y5 Y10 Y
Fund-0.39%-0.44%-0.37%-
Avg. of funds with same benchmark-0.39%-0.44%-0.37%-

Rolling Returns Analysis

Rolling annualized returns of Axis NIFTY Healthcare ETF-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
Metric1 Yr Rolling Returns3 Yr Rolling Returns5 Yr Rolling Returns7 Yr Rolling Returns
Analysis period26 May, 2022 - 24 Jul, 202604 Jun, 2024 - 24 Jul, 202601 Jun, 2026 - 24 Jul, 2026-
Average returns16.33%20.48%13.43%-
Standard deviation21.19%3.16%0.42%-
Best returns63.29%
1 year ending on 28 Mar, 2024
26.88%
3 years ending on 21 May, 2026
14.56%
5 years ending on 06 Jul, 2026
-
Worst returns-16.13%
1 year ending on 17 Jun, 2022
12.28%
3 years ending on 04 Jun, 2024
12.80%
5 years ending on 17 Jun, 2026
-
Period with positive return74.28%100.00%100.00%-
Period with return > 5%63.29%100.00%100.00%-
Period with return > 10%55.20%100.00%100.00%-
Period with return > 15%43.64%94.62%0.00%-
Beat % Category24.86%32.84%5.13%-
Beat % Benchmark60.31%53.62%84.62%-

Trailing Returns

Point-to-point returns of Axis NIFTY Healthcare ETF-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
11.2%
13.1%
13.0%
YTD
1.9%
2.1%
2.3%
1 M
16.6%
19.1%
18.2%
6 M
10.4%
10.3%
14.2%
1 Y
20.9%
21.0%
45.5%
3 Y
13.0%
13.3%
12.7%
5 Y
13.5%
8.7%
10 Y
Fund
Equity: Sectoral-Pharma
NIFTY Healthcare Total Return Index.
NameYTD1 M6 M1 Y3 Y5 Y10 YSince Inception
Fund11.18%1.93%16.64%10.43%20.95%12.96%-14.00%
Equity: Sectoral-Pharma13.13%2.07%19.12%10.34%21.02%13.29%13.50%-
NIFTY Healthcare Total Return Index.13.03%2.32%18.24%14.21%45.52%12.72%8.72%-
Rank in category21202315108--
Funds in category3033302918134-

Period Returns

Calendar-year, quarterly and monthly return history of Axis NIFTY Healthcare ETF-Growth. Toggle between bar chart and table view to analyse periodic performance trends.

Historical Performance

Track NAV movement and cumulative returns of Axis NIFTY Healthcare ETF-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.

Compare performance with respect to
Add benchmark

Frequently Asked Questions

What are the 1-year returns of Axis NIFTY Healthcare ETF-Growth?
Axis NIFTY Healthcare ETF-Growth has delivered a 1-year return of 10.43% as of 23 Jul 2026. During the same period, its benchmark NIFTY Healthcare Total Return Index. returned 14.21%. The fund has underperformed its benchmark over this period.
What are the 3-year returns of Axis NIFTY Healthcare ETF-Growth?
Axis NIFTY Healthcare ETF-Growth has delivered a 3-year CAGR of 20.95% as of 23 Jul 2026. Its benchmark NIFTY Healthcare Total Return Index. returned 45.52% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year ETF performance as it smooths out year-to-year volatility.
What are the 5-year returns of Axis NIFTY Healthcare ETF-Growth?
Axis NIFTY Healthcare ETF-Growth has delivered a 5-year CAGR of 12.96% as of 23 Jul 2026. Its benchmark NIFTY Healthcare Total Return Index. returned 12.72% CAGR over the same period. A 5-year track record is considered a more reliable indicator of fund quality than shorter-term performance, as it captures at least one full market cycle.
What are the returns of Axis NIFTY Healthcare ETF-Growth since inception?
Since its launch on 20 May 2021, Axis NIFTY Healthcare ETF-Growth has delivered a CAGR of 14.00%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has Axis NIFTY Healthcare ETF-Growth performed vs its category over the long term?
Over the long term, Axis NIFTY Healthcare ETF-Growth has ranked 10 out of 18 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and 8 out of 13 funds on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of Axis NIFTY Healthcare ETF-Growth?
The Sharpe ratio of Axis NIFTY Healthcare ETF-Growth is 0.94 (as of 23 Jul 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of Axis NIFTY Healthcare ETF-Growth?
The 3Y alpha of Axis NIFTY Healthcare ETF-Growth is -1.88% (as of 23 Jul 2026). Alpha measures the excess return generated by the fund over and above its benchmark NIFTY Healthcare Total Return Index., after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of Axis NIFTY Healthcare ETF-Growth?
The beta of Axis NIFTY Healthcare ETF-Growth is 0.98 (as of 23 Jul 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark NIFTY Healthcare Total Return Index.. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. Axis NIFTY Healthcare ETF-Growth's beta of 0.98 indicates it is more defensive than its benchmark.
What are the rolling returns of Axis NIFTY Healthcare ETF-Growth?
The average 1-year and 3-year rolling returns of Axis NIFTY Healthcare ETF-Growth is 16.33% and 20.48% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.